Maybe. But annualised earnings based on the first half is only 8c, so at $1.10 P/E is 13.75 on a stock with effectively one product with headwinds and a retreat in this half alone. Even if they do come home with a wet sail and get 12c, circa ten times is still too pricey for me on what is currently a one hit wonder.
Need to see those other products hitting the market to diversify AND increase revenue.
I like Acrux and its PDF status, but not at these prices and current outlook.
Ann: Half-Year Results Presentation - 31 December 2014, page-21
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
